Status:
COMPLETED
Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis
Lead Sponsor:
Prince of Songkla University
Conditions:
Exacerbation Copd
Bronchiectasis
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Roflumilast compare with placebo for decrease infected exacerbation in non-cystic Bronchiectasis
Detailed Description
Efficacy and RCT compare roflumilast vs placebo for 6 months in frequent infectious exacerbation in non-cystic bronchiectasis in Thailand
Eligibility Criteria
Inclusion
- symptomatic Bronchiectasis
- history at least 2 exacerbation last year
Exclusion
- comorbidity with chronic obstructive pulmonary disease
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04122547
Start Date
January 1 2015
End Date
December 1 2015
Last Update
October 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Songklanagarind hospital
Songkhla, Thailand, 90110